US$ 22.85
examples of glp 1 receptor agonists Frontiers GLP-1 receptor agonists and next-generation
Description
Cardiovascular Drugs and Therapy

S2CID 36908739
51 One significant challenge is the high rate of gastrointestinal adverse events associated with these compounds, which may be related to their pharmacokinetic properties and direct gastrointestinal irritation

Some employers have begun to include obesity medications as part of wellness initiatives, recognizing their potential to reduce long-term healthcare costs

16 Nonetheless, other GLP-1 RAs such as albiglutide has also shown reductions on MACE risk up to 22% as demonstrated by the HARMONY trial
